Form 4 for CLOV CLOVER HEALTH INVESTMENTS, CORP. /DE
Accepted 2024-12-17 00:00:00 ET · period of report 2024-12-14 · accession 0001801170-24-000249 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-12-17 | 2024-12-14 | CLOV | Wai Conrad | CEO, Counterpart Health | F - Tax | $3.11 | -98.2K | 3.37M | -3% | -$305.5K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2024-12-14 | F | D | 98,217 | $3.11 | 3,368,533 | D | — | — | (F1) Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations upon the vesting, on December 14, 2024, of 6.25% of the original number of time-based restricted stock units ("RSUs") granted to the Reporting Person on March 14, 2022. The remaining RSUs vest quarterly in equal installments of 6.25%, with a final vesting date occurring on March 14, 2026, subject to the continued service of the Reporting Person on each such vesting date. |